New studies reveal rare but real risk of GLP-1 drugs
July 22 (Reuters) – The risk of hair loss in patients taking GLP-1 drugs for obesity or diabetes, while low, is higher than with other diabetes drugs, new studies suggest. At two or more years after starting treatment, the odds of a new diagnosis of alopecia in GLP-1 users were 37 percent higher than in … Read more